Mechanical Ventilation

Published on 14/03/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1555 times

3 Mechanical Ventilation

Epidemiology

Patients with severe respiratory complaints account for about 12% of emergency department (ED) visits.1 Almost 800,000 hospitalizations per year involve mechanical ventilation, which costs nearly $27 billion and represents 12% of all hospital costs. Although the overall number of patients requiring mechanical ventilation is small (2.8%), the relative mortality is as high as 34%.2 Twenty-six percent of asthmatic patients who required intubation reported the ED as their primary source of health care.3 Thorough knowledge of noninvasive and invasive mechanical ventilation, lung-protective ventilation strategies, and methods to enhance patient-ventilator synchrony is essential in the practice of emergency medicine.

Treatment

Techniques and Methods of Mechanical Ventilation

Mechanical ventilatory support may be provided through a noninvasive or invasive approach. Furthermore, each technique may be applied with a variety of ventilator modes. The key differences in ventilatory support are determined by the trigger, the limit, and the cycle. The trigger is the event that starts inspiration: either patient-initiated or machine-initiated respiratory effort. Limit refers to the airflow parameter that is regulated during inspiration: either airflow rate or airway pressure. The cycle terminates inspiration: either a set volume is delivered (volume-cycled ventilation [VCV]), a pressure is delivered for a set period (pressure-cycled ventilation [PCV]), or the patient ceases inspiratory effort (pressure support ventilation [PSV]).

The plethora of terms associated with mechanical ventilation can cause confusion and misunderstanding, especially because some terms are used interchangeably. Knowing a few simple terms can improve understanding and aid management. The ventilator can be set to reach either a target volume or a target pressure. Other terms used for this target are cycle and limit. Volume cycled, volume limited, and volume targeted all refer to the same thing. Similarly, pressure cycled, pressure limited, and pressure targeted also refer to the same mode. “Control” breaths are ventilator-initiated breaths. “Assist” breaths are patient-initiated breaths. Therefore, a ventilator that is set on volume-targeted (cycled, limited) assist/control (AC) mode has breaths that are initiated by the patient (assist breaths) and the ventilator (control breaths) and reaches a set volume target (cycle, limit).

Modes of Invasive Mechanical Ventilation

Control Mode

Control mode ventilation (CMV) is used almost exclusively in anesthesia, but knowledge of this mode’s limitations aids in comprehension of other modes’ features (Fig. 3.1). In CMV, all breaths are triggered, limited, and cycled by the ventilator. In volume-targeted mode, the physician selects a tidal volume (VT), RR, inspiratory flow rate (IFR), fraction of inspired oxygen (FIO2), and positive end-expiratory pressure (PEEP). The machine then delivers positive pressure and applies as much pressure as required to deliver the set VT at the set IFR. (In pressure-targeted mode the physician sets the pressure high, RR, FIO2 and pressure low or PEEP.) Note that patients can set their own flow rate in pressure-targeted modes. The machine then delivers positive pressure and applies as much pressure as required to reach the set pressure high. The VT values generated are a function of respiratory system compliance. The patient is not able to initiate or terminate a breath. If inspiratory effort is initiated before the machine is triggered to deliver a breath, airflow would not occur regardless of the patient’s inspiratory effort. If exhalation is incomplete and the time for the machine to deliver a breath has occurred, the ventilator would provide as much pressure as necessary to cause inhalation. Imagine forcibly exhaling, or coughing, when the ventilator begins to deliver a breath. This lack of synchrony would cause distress and risk structural lung or airway injury. For these reasons, CMV is never used except for apneic, paralyzed, or anesthetized patients.

Assist/Control Mode

AC mode usually provides the greatest level of ventilatory assistance (Fig. 3.2). In volume-targeted ventilation, the physician sets VT, RR, IFR, FIO2, and PEEP. (In pressure-targeted mode, the physician sets the pressure high, RR, FIO2 and pressure low or PEEP.) In contrast to all other modes, the trigger that initiates inspiration can be either an elapsed time interval (determined by the set RR) or the patient’s spontaneous inspiratory effort. When either occurs, the machine delivers the set VT (in volume-targeted mode) or pressure high (in pressure-targeted mode). The machine follows a time algorithm that synchronizes the machine with patient-initiated breaths. If the patient is breathing at or above the set RR, all breaths are initiated by the patient. If the patient breathes below the set RR, machine-initiated breaths are interspersed among the patient’s breaths. Work of breathing (WOB) is primarily the effort that the patient exerts to cause airway pressure to drop to the threshold that triggers onset of the ventilator. (Manipulating the sensitivity of the ventilator sets this threshold.) Furthermore, WOB may be performed to a variable degree during inspiration, depending on how much the respiratory muscles are activated. WOB with the volume-targeted AC mode may be extreme in two situations: when the VT drawn by the patient is greater than the set VT and when the patient inspires at a rate that exceeds the set IFR (see later).

In the majority of situations, AC mode is used as described earlier and is termed volume-targeted or volume-cycled ventilation. As an alternative, some ventilators allow pressure-targeted (cycled) ventilation (PCV, not to be confused with PSV, described later) (Fig. 3.3). Instead of IFR, the limit during PCV is a set airway pressure. Instead of VT, the cycle during PCV is a set inspiratory time (TI). On some ventilator models, RR and the inspiratory-to-expiratory (I : E) ratio are set, and TI is calculated from these settings. On other models, TI is available as a setting. Because VT is not set, the VT delivered varies slightly from breath to breath, depending on lung compliance, airway resistance, and patient effort. PCV may offer a slight advantage over VCV in clinical scenarios that require control of the I : E ratio, but a body of literature investigating this concept does not exist. Historically, PCV was commonly used in neonates and infants, although modern ventilators that precisely measure small VT are currently favored. PCV may be the only mode available on some portable and transport ventilators.

Synchronized Intermittent Mandatory Ventilation and Pressure Support

Synchronized intermittent mandatory ventilation (SIMV) is probably the most commonly misunderstood mode of mechanical ventilation (Fig. 3.4). The physician sets VT, RR, IFR, FIO2, and PEEP, as in AC mode. In contrast to AC mode, however, the trigger that initiates inspiration depends on the patient’s RR relative to the set RR. When the patient breathes at or below the set RR, the trigger can be either elapsed time or the patient’s respiratory effort. In this case, WOB is equivalent to AC. When the patient breathes above the set RR, the ventilator is not triggered to assist in making spontaneous breaths in excess of the set RR. The work associated with such breaths may be quite high because the patient must generate enough negative force to pull air through the ventilator and overcome the resistance to airflow caused by the ventilator circuit tubing and the endotracheal tube (ETT), in addition to the WOB required as a result of the underlying disease process.

This limitation of SIMV can be diminished by the addition of PSV (Fig. 3.5). PSV causes inspiratory positive pressure to be applied during patient-initiated breaths that exceed the set RR. The patient initiates and terminates inspiration, thereby determining VT. Once the patient triggers pressure support, it is maintained until the machine detects cessation of patient effort, as indicated by a fall in inspiratory airflow. VT, IFR, and TI are not controlled but instead are determined by patient effort. The WOB performed during PSV involves triggering the ventilator to deliver the pressure and maintaining inspiratory effort throughout inhalation. Contrast this with machine-assisted ventilation in AC or SIMV, where WOB involves triggering the ventilator but lung inflation continues regardless of the patient’s inspiratory effort. WOB during PSV also depends on the set level of pressure support. Insufficient pressure support is associated with high WOB, which leads to a small VT and a high RR. Adequate pressure support reduces WOB and improves VT and RR. Many experts view RR as the best index of the adequacy of the level of pressure support. It should be adjusted to maintain an acceptable RR of less than 30 but preferably less than 24 breaths per minute.

SIMV can be used in pressure-targeted ventilation. Essentially, the ventilator is set to reach a target pressure for each of the ventilator-initiated breaths and potentially a different target for patient-initiated breaths. Another way to consider pressure-targeted SIMV is as PSV with a set rate.

Monitoring Dynamic Pressure During Invasive Ventilation

Mechanical ventilation can cause damage to the lungs on a macroscopic and microscopic level. The direct cause of lung injury is believed to be a combination of overdistention of the alveoli and repetitive alveolar opening and closing with shear of the alveolar wall. The concept of ventilator-induced lung injury (VILI) has evolved to encompass all forms of injury at the organ and alveolar level, including pneumothorax, pneumomediastinum, bronchial rupture, diffuse alveolar damage, and acute respiratory distress syndrome (ARDS). Pressure is measured at the ventilator end of the circuit (the proximal part of the airway), and this measurement is used as an index of the pressure within the lung.

Intrinsic Positive End-Expiratory Pressure

PEEP indicates that the airway pressure measured at the end of exhalation is above ambient air pressure. When PEEP is set by the clinician and applied by the ventilator, it is termed extrinsic PEEP (PEEPe). In contrast, intrinsic PEEP (PEEPi) arises when exhalation is incomplete because of either intrathoracic airway obstruction, early airway closure during exhalation, or inadequate exhalation time. The common end point is trapping of air in the lung at the end of exhalation, which ultimately leads to increased intrathoracic pressure. PEEPi can cause problems through several mechanisms. First, because exhalation is incomplete, air is progressively being trapped in the lungs, thereby leading to early airway closure and dynamic hyperinflation with an associated risk for VILI. Second, PEEPi leads to difficulty triggering the ventilator and increased WOB, as discussed previously. Third, PEEPi can cause patient-ventilator dyssynchrony when the patient continues active contraction of the respiratory muscles at end exhalation as the ventilator is triggered. Lung inflation may begin while the patient is attempting to complete exhalation. Finally, increased intrathoracic pressure can impede venous return to the heart and consequently lead to hemodynamic instability. Simultaneously, impaired venous return may compromise pulmonary blood flow, increase physiologic dead space, and result in worsening hypercapnia. Control of PEEPi is discussed later.

Modes of Noninvasive Mechanical Ventilation

The cause of the respiratory failure is the best predictor of whether a patient will respond to noninvasive techniques. The literature supports the application of NPPV for certain conditions—COPD,4,5 asthma,6 congestive heart failure (CHF),7,8 pneumonia, trauma, cancer, and neuromuscular disease—as well as for pediatric patients.

Noninvasive ventilators are more portable because of the use of a smaller air compressor/blower, but they cannot develop pressures as high as larger critical care ventilators can. A noninvasive ventilator can provide up to 20 to 40 cm H2O of air pressure, as compared with critical care ventilators capable of delivering greater than 100 cm H2O of air pressure. Newer noninvasive ventilators can be set for volume- or pressure-targeted mode, AC or SIMV, and even proportional assist.

Spontaneous and Spontaneous/Timed Modes

In spontaneous mode, airway pressure cycles between inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). This mode is commonly referred to as biphasic (or bilevel) positive airway pressure, but other proprietary names refer to the same mode. The trigger to switch from EPAP to IPAP is the patient’s inspiratory effort. A variety of ventilator models use one or several of the following to indicate patient effort: a drop in airway pressure, measured inspired volume (usually 5 to 6 mL), or an increase in airflow rate. The limit during inspiration is the set level of IPAP. The inspiratory phase cycles off when the machine senses cessation of patient effort, as indicated by a decrease in inspiratory flow below a set threshold (typically 60% of the peak IFR) or attainment of maximum inspiratory time (usually 3 seconds). The latter is a safety mechanism to prevent lung hyperinflation as a result of ventilator “runaway,” but it was not available on early generations of noninvasive ventilators. VT may vary from breath to breath, dependent primarily on the magnitude and duration of patient effort, but also on lung compliance. WOB is predominantly related to initiating and maintaining airflow throughout the inspiratory phase. Additional WOB may occur if the patient actively contracts the expiratory muscles.

Spontaneous mode is dependent on the patient’s effort to trigger inhalation. Respiratory acidosis will develop in a patient breathing at a slow, inadequate rate. To prevent this adverse consequence, spontaneous/timed mode allows the machine to be triggered either by patient effort or after an elapsed time interval that is calculated from a set minimum RR. If the patient does not initiate inspiration during the set interval, IPAP is triggered. For machine-initiated breaths, the machine cycles back to EPAP based on a set inspiratory time. For patient-initiated breaths, the ventilator cycles as it would in spontaneous mode.

Pragmatically, NPPV (noninvasive) and PSV (invasive) are similar but have a few noteworthy differences. First, the trigger for PSV is a drop in airway pressure sensed by the ventilator. Some ventilators monitor airflow in the inspiratory and expiratory limbs of the ventilator circuit and will be triggered if airflow in the inspiratory limb is greater than airflow in the expiratory limb. The sensitivity of the trigger can be adjusted on a conventional ventilator by setting the magnitude of the change in pressure required for triggering. This is contrasted with NPPV, in which sensitivity is continuously and automatically adjusted by the noninvasive ventilator based on the amount of air leak and is not able to be adjusted by the physician. Second, because PSV is supplied by a critical care ventilator, leaks are not tolerated or compensated. Because airflow through a leak may be misinterpreted in this mode as patient inspiratory effort, a leak may lead to early triggering before exhalation is complete. Leaks may also cause failure to cycle off in synchrony with cessation of patient effort. These phenomena are less likely to occur when using a noninvasive ventilator. Finally, the nomenclature used for airway pressure is different. Pressure during the expiratory phase is termed PEEP, analogous to the EPAP of NPPV. Pressure during the inspiratory phase is termed peak inspiratory pressure, analogous to the IPAP of spontaneous mode. The distinction is that in PSV the numerical value for pressure support is the equivalent of the difference between IPAP and EPAP.

Initiation of Noninvasive Positive Pressure Ventilation

The process of initiating a trial of noninvasive ventilatory support consists of four basic steps. First, the patient must be willing to accept face mask ventilation. Because the patient should remain awake and cooperative during ventilation, the process should be explained before the mask is applied. Initially, an FIO2 of 100% with 3 to 5 cm H2O of CPAP is provided. Acceptance may improve if the patient holds the mask against the face. The mask is secured with straps once the patient demonstrates acceptance.

Next, after explaining that the pressure will change, ventilation is switched to NPPV with an EPAP of 3 to 5 cm H2O and an IPAP of 8 to 10 cm H2O. IPAP is titrated in 2– to 3–cm H2O increments until exhaled VT (measured by the ventilator) is in the range of 6 to 9 mL/kg IBW. Further adjustment of IPAP should be directed toward obtaining an RR of less than 30. Another option is to start with high IPAP (20 to 25 cm H2O) and titrate down based on patient comfort. Of note, no studies have compared a low-to-high IPAP versus a high-to-low IPAP approach.

EPAP is then adjusted to the lowest level that allows synchrony between the patient and ventilator. Understanding this process requires review of the components of WOB related to triggering the ventilator. The patient activates the inspiratory muscles to decrease intrathoracic pressure. As intrathoracic pressure falls below airway pressure, transpulmonary pressure becomes positive, airflow begins, and the ventilator is triggered. In a normal patient, the inspiratory muscle force required to lower intrathoracic pressure to a level that triggers the ventilator is not great. In a patient with high PEEPi (also known as auto-PEEP), intrathoracic pressure is high at end exhalation. The inspiratory muscle force required to lower intrathoracic pressure below airway pressure is significantly greater. Thus the WOB that is performed to trigger the ventilator is proportional to the amount of PEEPi that is present.

While delivering NPPV, it is impossible to measure PEEPi without invasive means. Instead, to detect PEEPi, signs of difficulty triggering the ventilator or signs of expiratory airflow obstruction should be sought. On physical examination, recruitment of the accessory muscles of inspiration suggests that PEEPi is a problem. A useful technique is palpation of the sternocleidomastoid muscle while simultaneously watching the ventilator flow graphs or listening for the ventilator to trigger. When the muscle is felt to contract before the ventilator triggers, PEEPi may be the culprit. Observation of active abdominal muscle recruitment during exhalation indicates airflow obstruction as a cause of elevated PEEPi. When elevated PEEPi is suspected, EPAP should be increased in increments of 2 to 3 cm H2O until the problem is controlled. The maximum safe level of EPAP that should be used during NPPV has not been determined in an evidence-based manner. Typical initial settings range from 0 to 5 cm H2O; maximum settings described in the methods sections of various trials range from 12.5 to 15 cm H2O. It is prudent to measure the heart rate and blood pressure and perform pulse oximetry after each increase in EPAP because high levels may compromise cardiac output. As EPAP is increased, corresponding increasing increments in IPAP are required to maintain a differential between EPAP and IPAP that ensures adequate VT.

Finally, FIO2 is adjusted to maintain adequate O2 saturation. In many clinical situations, continuous pulse oximetry alone is adequate for this purpose. Arterial blood gas determinations are not routinely required but may be helpful in select patients to assess improvement in respiratory acidosis.

Specific Disease Processes

Controlling Airway Pressure—Lung-Protective Ventilator Strategies

Causes of difficulty with mechanical ventilation fall into four general categories:

Acute Respiratory Distress, Acute Lung Injury, and Pulmonary Edema

Elevated plateau pressure is encountered in patients with poor lung compliance as a result of parenchymal lung disease (e.g., pulmonary edema, either cardiogenic or noncardiogenic) or obstructive airways disease with air trapping. The goal is to support the respiratory system while avoiding iatrogenic injury.

Initial studies compared a conventional ventilation strategy (VT of 10 to 15 mL/kg IBW with a goal of obtaining normal PaO2 and PaCO2) with a lung-protective ventilation strategy (VT of 6 to 8 mL/kg IBW with correction of hypoxia, but allowing hypercapnia in favor of avoiding high airway pressure). The results were conflicting.913 A landmark study, the ARDS Network Trial,14 prospectively compared a conventional strategy (VT of 12 mL/kg and a Pplat limit of 50 cm H2O) with a protective strategy (VT of 6 mL/kg IBW and a Pplat limit of 30 cm H2O). After enrollment of 861 patients with ARDS and an interim analysis, the trial was stopped early because of a 22% reduction in mortality, 20% fewer days requiring mechanical ventilation, and fewer cases of organ system failure in the group receiving the lung-protective strategy.

The mechanical ventilation strategy in patients with other disease processes has not been studied as extensively. Extrapolation of these findings to patients with CHF, ALI, pneumonia, pulmonary fibrosis, pulmonary contusion, lung cancer, and other lung pathology is not based on experimental evidence.

In summary, based on the available literature, a lung-protective strategy should be used that involves low VT, limitation of Pplat to 30 cm H2O, and permissive hypercapnia in a patient with ARDS or pulmonary edema to avoid iatrogenic lung injury. This ARDSnet strategy should also be considered in patients with the diffuse infiltrative lung diseases mentioned earlier.

Obstructive Airways Disease

Exacerbation of obstructive airways disease requiring mechanical ventilation is often associated with air trapping and dynamic hyperinflation of the lungs. High Ppeak arises as a result of inspiratory airflow resistance, a phenomenon more common in patients with severe asthma than in those with COPD. High Pplat is caused by lung overdistention and consequent diminished compliance. Patients with both high Ppeak and Pplat comprise a group of high-risk patients with both obstruction and overdistention who are at high risk for complications, including pneumothorax, tension pneumothorax, pneumomediastinum, dysrhythmias, and hemodynamic collapse. No prospective trials comparing ventilation strategies in such patients have been conducted. It is common practice to use a strategy of permissive hypercapnia to eliminate PEEPi and avoid high Pplat. This strategy makes use of low VT, low RR, and high IFR to shorten the inspiratory time and prolong the expiratory time. Although this strategy often leads to hypercapnia, it is considered safer to allow respiratory acidosis to develop than to ventilate at excessive airway pressure. A lower limit of acceptable pH has not been established, but general recommendations have been to allow pH values as low as 7.15 to 7.2. Permissive hypercapnia is required more often in the management of status asthmaticus than in the management of COPD. Evidence in support comes from retrospective studies. Current recommendations include VT less than 8 mL/kg IBW, an initial RR of 8 to 10 cycles/min, and FIO2 adjusted to obtain a PaO2 of approximately 60 mm Hg or a PaO2 of 85% to 88%. The concept of permissive hypercapnia and controlled hypoventilation in the management of acute asthma exacerbation has been widely accepted.15 Some reports suggest that Ppeak and Pplat are not adequate indicators of pulmonary hyperinflation16 and recommend that expiratory volumes be measured in these patients.17 This latter technique has not gained widespread acceptance, however.

Follow-Up, Next Steps In Care, and Patient Education

Patients placed on mechanical ventilation (either invasive or noninvasive) require admission to the hospital. Some centers are able to manage NPPV outside the intensive care unit, but this should be considered only in patients who have demonstrated marked improvement and are on minimal settings. Patients admitted to the floor with NPPV should still be monitored carefully.

Patients who required NPPV during their ED course and subsequently improve to the point where they no longer needed mechanical ventilation should be considered for admission or observation. Asthmatic patients who have improved may be considered for discharge, but only after a period of observation.

Occasionally, patients with chronic respiratory failure will be seen in the ED. Evaluation of such patients should be based on their chief complaint. Determination for admission is essentially the same as for other patients. If admission is required for simple issues, these patients will need to be admitted to the intensive care unit because it is the only location with personnel trained to manage the ventilator.

Complications

Invasive Mechanical Ventilation

In the ED, complications of mechanical ventilation (Box 3.1) can begin during the preintubation period. Induction agents may cause or worsen hypotension. Overly aggressive bag-valve-mask ventilation may lead to decreased venous return and hypotension. Airway trauma and mechanical complications may be caused by the act of intubation. Initiating mechanical ventilation and transitioning from negative pressure ventilation to positive pressure ventilation may lead to hypotension. Positive pressure ventilation may worsen an existing pneumothorax or give rise to pneumothorax. Auto-PEEP (also known as PEEPi, dynamic hyperinflation, breath stacking) can lead to hypotension and circulatory collapse. Ventilator-associated lung injury can be caused by barotrauma, volutrauma, or trauma related to atelectasis. Long-term complications can include inability to be liberated from the ventilator, ventilator-associated pneumonia, tracheal stenosis, and vocal cord injury.

Some of the commonly underrecognized problems that arise in the support of critically ill patients fall into the category of patient-ventilator dyssynchrony. These situations can markedly increase WOB and lead to increased CO2 and lactic acid production with both respiratory and metabolic acidosis.

Intrinsic Positive End-Expiratory Pressure

Maneuvers directed at elimination of PEEPi have in common the effect of decreasing inspiratory time and therefore providing more expiratory time. Decreasing RR and VT and increasing IFR effectively accomplish this goal. Frequently, this cannot be achieved without sedation, sometimes requiring the addition of pharmacologic paralysis.

References

1 McCaig LF, Ly N. National hospital ambulatory medical care survey: 2000 emergency department summary. Advance Data. April 22, 2002.

2 Wunsch H, Linde-Zwirble W, Angus D, et al. The epidemiology of mechanical ventilation use in the United States. Crit Care Med. 2010;38:1947–1953.

3 Moore BB, Wagner R, Weiss KB. A community based study of near-fatal asthma. Ann Allergy Asthma Immunol. 2001;86:190–195.

4 Ram FS, Picot J, Lightowler J, et al. Noninvasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. (3):2004. CD004104

5 Conti G, Antonelli M, Navalesi P, et al. Noninvasiveness vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial. Intensive Crit Care Med. 2002;28:1701–1707.

6 Soroksky A, Stay D, Shpirer I. A pilot, prospective, placebo-controlled trial of bilevel positive airway pressure in acute asthma attack. Chest. 2003;123:1018–1025.

7 Peter JV, Moran JL, Phillips-Hughes J, et al. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet. 2006;367:1155–1163.

8 Weng CL, Zhao YT, Liu QH, et al. Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med. 2010;152:590–600.

9 Bower RG, Shanholtz CB, Fessler HE, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med. 1999;27:1492–1498.

10 Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med. 1998;338:355–361.

11 Brochard L, Roudot-Thoraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;158:1831–1838.

12 Amato MBP, Barbas CSV, Medeiros DM, et al. Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338:347–354.

13 Amato MBP, Barbas CSV, Medeiros DM, et al. Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:1835–1846.

14 The Acute Respiratory Distress Syndrome Network Authors. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308.

15 Slutsky AS. Mechanical ventilation. American College of Physicians’ Consensus Conference. Chest. 1993;104:1833–1859.

16 Williams TJ, Tuxen DV, Scheinkestel CD, et al. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis. 1992;146:607–615.

17 Tuxen DV, Williams TJ, Scheinkestel CD, et al. Use of a measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma. Am Rev Respir Dis. 1992;146:1136–1142.